- AZD1222 US Phase III primary analysis confirms safety and efficacy https://www.astrazeneca.com/media-centre/press-releases/2021/azd1222-us-phase-iii-primary-analysis-confirms-safety-and-efficacy.html 4 comments europe
- Update on the safety of COVID-19 Vaccine AstraZeneca https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2021/update-on-the-safety-of-covid-19-vaccine-astrazeneca.html 31 comments europe
- Covid-19: Oxford University vaccine shows 70% protection https://www.astrazeneca.com/media-centre/press-releases/2020/azd1222hlr.html 77 comments stocks
- AZN's ZS-9 receives CRL https://www.astrazeneca.com/media-centre/press-releases/2016/astrazeneca-receives-complete-response-letter-from-us-fda-for-sodium-zirconium-cyclosilicate-zs-9-for-oral-suspension-for-treatment-of-hyperkalaemia-27052016.html 19 comments wallstreetbets